160 related articles for article (PubMed ID: 18723356)
41. C-Glucosylated malonitrile as a key intermediate towards carbohydrate-based glycogen phosphorylase inhibitors.
Feuillastre S; Chajistamatiou AS; Potamitis C; Zervou M; Zoumpoulakis P; Chrysina ED; Praly JP; Vidal S
Bioorg Med Chem; 2012 Sep; 20(18):5592-9. PubMed ID: 22910227
[TBL] [Abstract][Full Text] [Related]
42. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
Watson KA; Chrysina ED; Tsitsanou KE; Zographos SE; Archontis G; Fleet GW; Oikonomakos NG
Proteins; 2005 Dec; 61(4):966-83. PubMed ID: 16222658
[TBL] [Abstract][Full Text] [Related]
43. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme.
Humljan J; Kotnik M; Contreras-Martel C; Blanot D; Urleb U; Dessen A; Solmajer T; Gobec S
J Med Chem; 2008 Dec; 51(23):7486-94. PubMed ID: 19007109
[TBL] [Abstract][Full Text] [Related]
44. Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.
Czifrák K; Páhi A; Deák S; Kiss-Szikszai A; Kövér KE; Docsa T; Gergely P; Alexacou KM; Papakonstantinou M; Leonidas DD; Zographos SE; Chrysina ED; Somsák L
Bioorg Med Chem; 2014 Aug; 22(15):4028-41. PubMed ID: 25009003
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
Hill TA; Gordon CP; McGeachie AB; Venn-Brown B; Odell LR; Chau N; Quan A; Mariana A; Sakoff JA; Chircop M; Robinson PJ; McCluskey A
J Med Chem; 2009 Jun; 52(12):3762-73. PubMed ID: 19459681
[TBL] [Abstract][Full Text] [Related]
46. Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.
Chen J; Liu J; Zhang L; Wu G; Hua W; Wu X; Sun H
Bioorg Med Chem Lett; 2006 Jun; 16(11):2915-9. PubMed ID: 16546381
[TBL] [Abstract][Full Text] [Related]
47. Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors.
Birch AM; Kenny PW; Oikonomakos NG; Otterbein L; Schofield P; Whittamore PR; Whalley DP
Bioorg Med Chem Lett; 2007 Jan; 17(2):394-9. PubMed ID: 17095214
[TBL] [Abstract][Full Text] [Related]
48. Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
Oikonomakos NG; Tiraidis C; Leonidas DD; Zographos SE; Kristiansen M; Jessen CU; Nørskov-Lauritsen L; Agius L
J Med Chem; 2006 Sep; 49(19):5687-701. PubMed ID: 16970395
[TBL] [Abstract][Full Text] [Related]
49. van der Waals interactions govern C-β-d-glucopyranosyl triazoles' nM inhibitory potency in human liver glycogen phosphorylase.
Kantsadi AL; Stravodimos GA; Kyriakis E; Chatzileontiadou DSM; Solovou TGA; Kun S; Bokor É; Somsák L; Leonidas DD
J Struct Biol; 2017 Jul; 199(1):57-67. PubMed ID: 28483603
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies.
Saxena AK; Pandey G; Gupta S; Singh AB; Srivastava AK
Bioorg Med Chem Lett; 2009 Apr; 19(8):2320-3. PubMed ID: 19282172
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
Varga G; Docsa T; Gergely P; Juhász L; Somsák L
Bioorg Med Chem Lett; 2013 Mar; 23(6):1789-92. PubMed ID: 23395662
[TBL] [Abstract][Full Text] [Related]
52. Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives.
Karis ND; Loughlin WA; Jenkins ID; Healy PC
Bioorg Med Chem; 2009 Jul; 17(13):4724-33. PubMed ID: 19443226
[TBL] [Abstract][Full Text] [Related]
53. Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides.
Moreno-Díaz H; Villalobos-Molina R; Ortiz-Andrade R; Díaz-Coutiño D; Medina-Franco JL; Webster SP; Binnie M; Estrada-Soto S; Ibarra-Barajas M; León-Rivera I; Navarrete-Vázquez G
Bioorg Med Chem Lett; 2008 May; 18(9):2871-7. PubMed ID: 18424136
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase.
Yano S; Kazuno H; Sato T; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
Bioorg Med Chem; 2004 Jul; 12(13):3443-50. PubMed ID: 15186830
[TBL] [Abstract][Full Text] [Related]
55. Stereoselective synthesis of bioactive isosteviol derivatives as alpha-glucosidase inhibitors.
Wu Y; Yang JH; Dai GF; Liu CJ; Tian GQ; Ma WY; Tao JC
Bioorg Med Chem; 2009 Feb; 17(4):1464-73. PubMed ID: 19167896
[TBL] [Abstract][Full Text] [Related]
56. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase.
Anagnostou E; Kosmopoulou MN; Chrysina ED; Leonidas DD; Hadjiloi T; Tiraidis C; Zographos SE; Györgydeák Z; Somsák L; Docsa T; Gergely P; Kolisis FN; Oikonomakos NG
Bioorg Med Chem; 2006 Jan; 14(1):181-9. PubMed ID: 16213146
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
Zhang L; Jia X; Dong J; Chen D; Liu J; Zhang L; Wen X
Chem Biol Drug Des; 2014 Mar; 83(3):297-305. PubMed ID: 24119242
[TBL] [Abstract][Full Text] [Related]
58. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and glycogen phosphorylase inhibitor activity of 2,3-dihydrobenzo[1,4]dioxin derivatives.
Juhász L; Docsa T; Brunyászki A; Gergely P; Antus S
Bioorg Med Chem; 2007 Jun; 15(12):4048-56. PubMed ID: 17451960
[TBL] [Abstract][Full Text] [Related]
60. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.
Wang Y; Yan Z; Guo Y; Zhang L
Future Med Chem; 2021 May; 13(10):897-909. PubMed ID: 33906369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
